close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Terns Pharmaceuticals, Inc. - Common Stock (NQ:TERN)

37.91 -0.07 (-0.18%)
Streaming Delayed Price Updated: 10:17 AM EST, Feb 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Terns Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
8 Analysts Have This to Say About Terns Pharma ↗
 
Via Benzinga
News headline image
Terns Pharmaceuticals Announces Publication of TERN-701 Trial-in-Progress Abstract for the 2023 ASCO Annual Meeting
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Terns Pharmaceuticals to Present at Upcoming Investor Conferences
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Expert Ratings for Terns Pharma ↗
 
Via Benzinga
News headline image
Terns Pharmaceuticals to Highlight New Preclinical Data for TERN-601 Program in Obesity at the American Diabetes Association’s 83rd Annual Scientific Sessions
TERN-601 (oral GLP-1) program in obesity on track to initiate Phase 1 clinical trial in second half of 2023 with initial proof of concept data anticipated in 2024 
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Terns Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Updates
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Terns Pharmaceuticals to Participate in the JMP Securities 2023 Life Sciences Conference
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Why Shares of Terns Pharmaceuticals Soared This Week ↗
The company is showing progress toward a NASH therapy. 
Via The Motley Fool
News headline image
The Latest Analyst Ratings for Terns Pharma ↗
 
Via Benzinga
News headline image
Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 8, 2023 ↗
 
Via Benzinga
News headline image
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Terns Pharmaceuticals Shares Are Trading Higher Today ↗
Terns Pharmaceuticals (NASDAQ: TERN) shares are trading higher on Tuesday after the company reported Q4 financial results. 
Via Benzinga
News headline image
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Terns Pharmaceuticals Appoints Emil Kuriakose, M.D., as Chief Medical Officer of Terns Oncology
Experienced Leader Brings Extensive Clinical Development and Medical Affairs Expertise in Oncology 
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Terns Pharmaceuticals Provides Program Updates and Announces Participation at Upcoming March Investor Conferences
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2023 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 7, 2023 ↗
 
Via Benzinga
News headline image
Terns Pharmaceuticals to Participate in Guggenheim Healthcare Talks 2023 Oncology Conference
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Terns Pharmaceuticals to Present at B. Riley Securities’ 3rd Annual Oncology Conference
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company announced it has been awarded a multiple award $900 million Indefinite Delivery/Indefinite Quantity... 
Via Benzinga
News headline image
CommVault Systems, Halozyme Therapeutics And Other Big Stocks Moving Lower On Wednesday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 80 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Terns Pharmaceuticals to Highlight 2023 Priorities and Clinical Milestones at the 41st Annual J.P. Morgan Healthcare Conference
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Tesla To $250? Here Are 10 Other Price Target Changes For Thursday ↗
Morgan Stanley cut Tesla, Inc. (NASDAQ: TSLA) price target from $330 to $250. Morgan Stanley analyst Adam Jonas maintained an Overweight rating on the stock. Tesla shares rose 4.4% to $117.65 in... 
Via Benzinga
News headline image
$2.4 Million Bet On Duolingo? Check Out These 3 Stocks Insiders Are Buying ↗
Although US stocks closed lower on Wednesday, there were a few notable insider trades. 
Via Benzinga
News headline image
$5.5 Million Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying ↗
Although US stocks closed higher on Friday, there were a few notable insider trades. 
Via Benzinga
News headline image
Terns Announces Closing of Public Offering of Shares of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today